Evaluation of Transient Dyspnea During Gadoxetic Acid Enhanced Multiphasic Liver MRI

Seoul National University

Status: Completed

Conditions: Dyspnea

Treatments: Drug: gadoxetic acid; Other: Magnetic resonance imaging (MRI)

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02395991

CS_2015_ISS

Details and patient eligibility

About

The purpose of this study is to observe transient dyspnea pattern after Gd-EOB-DTPA administration by obtaining continuous dynamic T1 weighted image data.

Enrollment: 60 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who are referred to MR unit for hepatocyte-specific contrast enhanced liver MRI using gadoxetic acid, to characterize focal liver lesion or to investigate diffuse liver disease
• OR, Liver living donor candidates
• AND subjects who sign the informed consent.

Exclusion criteria

• Minors under 18 years old
• All contraindication to MRI
• Hypersensitivity to Gd
• Biliary obstruction

Trial design

60 participants in 1 patient group

Observe1

Description:

Patients who are referred to MR unit for hepatocyte-specific contrast (gadoxetic acid) enhanced liver magnetic resonance imaging (MRI)

Treatment:

Other: Magnetic resonance imaging (MRI)

Drug: gadoxetic acid